Intravenous Drug Use Rates and Results of Direct-acting Antiviral Treatment in Prisoner Patients
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 2
Abstract
Objectives: Intravenous drug use (IVDU) is more common in prisoner patients, and this is a global problem. Hepatitis C virus (HCV) infection is higher in prisoners than general population. In our study, we aimed to examine the IVDU rates and direct-acting antiviral (DAA) treatment results of the prisoners who applied to Hatay Mustafa Kemal University Clinic of Infectious Diseases. Materials and Methods: In our study, IVDU rates and HCV treatment results of 85 prisoners who applied to Hatay Mustafa Kemal University Faculty of Medicine Clinic of Infectious Diseases between January 2017 and December 2019 were retrospectively analyzed. Treatment results were evaluated by performing modified intention to tract (mITT) and per protocol (PP) efficacy analysis, respectively. Results: The rate of IVDU was 37.7% in prisoners who were positive for HCV. Although sustained virological response (SVR) rate was 100% in PP analysis, SVR rate was determined as 80.5% in mITT analysis. Viral genotype 3 (41.6%) and genotype 4 (39%) were the most common. Conclusion: However, data on HCV screening and treatment in prisons in Turkey is inadequate or too low. We think that with the use of DAAs, patients’ compliance to treatment will increase, it is an important step for HCV eradication and multicenter studies should be conducted.
Authors and Affiliations
Mehmet Çabalak, Tayibe Bal
The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience
Objectives: Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir (PrOD) seems to be highly effective and safe in chronic haemodialysis (CHD) patients. We presented our experiences of treatment with PrOD in CHD patients. Material...
The Evaluation of the Relation Between Drug Compliance and Psychometric Tests in Chronic B Hepatitis Patients Who are Treated with Oral Antivirals
Objectives: Hepatitis B is a viral infection that causes acute and chronic hepatitis and serious complications such as cirrhosis and hepatocellular cancer. Several psychiatric symptoms and depression, particularly anxiet...
Comparison of Liver Histopathology with Non-invasive Inflammation Markers as Neutrophil-lymphocyte Ratio, Platelet-lymphocyte Ratio and Mean Platelet Volume in Chronic Hepatitis B Patients
Objectives: Platelet-lymphocyte ratio (PLR) and neutrophillymphocyte ratio (NLR) are commonly studied non-invasive inflammatory markers in cancer patients. There are some studies showing its association with fibrosis in...
Direct-acting Antiviral Therapy for Mixed Genotype Chronic Hepatitis C Infection
Objectives: Literature data concerning the outcomes of direct acting antiviral (DAA) therapy in mixed genotype hepatitis C virus (HCV) infections are very limited, and the incidence of mixed HCV infection in Turkey is un...
An Evaluation of Hepatitis B Virus and Hepatitis C Virus Frequency and the Anti-hepatitis B Surface Seropositivity of Syrian Refugees in the Karabük Province
Objectives: To investigate the frequency of hepatitis B Virus (HBV) and HCV with anti- hepatitis B Surface (HBs) seropositivity using serological and molecular methods in Syrian refugees in the Karabük. Materials and Me...